CASP3 and hepatocellular carcinoma: And miR-122 directly targets the 3‘-UTR binding site of the endogenous apoptosis regulator Bcl-w to cause the reduction of mRNA and protein expression of Bcl-w, which thus inhibiting cancer cell viability and activating caspase-3 and finally promoting HCC cell apoptosis [27].